Johnson & Johnson on Thursday asked US regulators to clear its COVID-19 vaccine, the first of the various vaccines to be a single-dose vaccine, The Associated Press reports.
J&J’s vaccine was safe and offered strong protection against moderate to severe COVID-19, according to preliminary results from a massive international study.